Home

FOR ADVANCED THERAPEUTICS

HIGH PERFORMANCE CELL TECHNOLOGIES

STABLE AAV PRODUCER CELL LINES

ELEVECTA®

CEVEC is a leading provider of high-performance cell technology for the manufacturing of advanced bio-therapeutics from R&D to manufacturing scale. The company’s product portfolio comprises various platform technologies for gene therapy vectors, vector vaccines and complex recombinant proteins.

In the viral vector space, ELEVECTA® is the technology of choice for AAV manufacturing. For RCA-free Adenoviral vectors,  the CAP® Ad Technology is the perfect fit. CAP® Go is the solution to enable the production of complex and highly glycosylated recombinant proteins.

STABLE AAV PRODUCER CELL LINES

RCA-FREE ADENOVIRAL VECTORS

GLYCO-OPTIMIZED PROTEINS

Cell & Gene Meeting on the Mesa
Hybrid / Carlsbad, USA

Live: 10/12/2021 – 10/14/2021
Virtual: 10/19/2021 – 10/20/2021

OPEN POSITIONS (M/F/D)

  • TECHNISCHER ASSISTENT CELL TECHNOLOGY

KEEP IN TOUCH

Subscribe to receive CEVEC’s latest Press Releases, Conference Information and Webinar Invitations according to our Privacy Policy.

© CEVEC Pharmaceuticals GmbH 2021